Verification of the Dystonic Muscles Using F-18-Fluorodeoxyglucose Positron Emission Tomography in a Patient with Cervical Dystonia

被引：0
|
作者：
Choi, Kyung Pil [1 ]
Chung, Chin Wook [1 ]
Sung, Duk Hyun [1 ]
机构：
[1] Sungkyunkwan Univ, Dept Phys Med & Rehabil, Samsung Med Ctr, Sch Med, Seoul, South Korea
来源：
ANNALS OF REHABILITATION MEDICINE-ARM | 2010年 / 34卷 / 01期
关键词：
Cervical dystonia; Botulinum toxin; Positron emission tomography;
D O I：
暂无
中图分类号：
R49 [康复医学];
学科分类号：
100215 ;
摘要：
Treatment of choice for cervical dystonia is botulinum toxin (BTX) injection and surgical interventions can be tried in refractory cases. Success of BTX injection depends on precise muscle selection and adequate dosage of BTX. F-18-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) can evaluate the metabolism of the superficial and deep cervical muscles with high resolution and may be useful for identifying dystonic muscles in CD. We report a satisfactory result of BTX injection using F-18-FDG PET/CT for identification of dystonic muscles in a patient with cervical dystonia who previously failed to respond to botulinum toxin injection and denervation operation.
引用
收藏
页码：91 / 95
页数：5
相关论文
共 50 条
  • [1] Usefulness of F-18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Management of Cervical Dystonia
    Lee, Han Byul
    An, Young-Sil
    Lee, Hyun Young
    Hwang, Jee Hyun
    Lee, Hyun Jung
    Jeong, Kil Yong
    Kim, Jong Woo
    Yim, Shin-Young
    ANNALS OF REHABILITATION MEDICINE-ARM, 2012, 36 (06): : 745 - 755
  • [2] Laterality and psychosis: A study using F-18-fluorodeoxyglucose and positron emission tomography
    AlMousawi, AH
    Evans, N
    Roeda, D
    Chaloner, F
    Ashcroft, GW
    SCHIZOPHRENIA RESEARCH, 1996, 18 (2-3) : XIIE1 - XIIE1
  • [3] LOCALIZATION OF DYSTONIC MUSCLES WITH POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY FOR THE TREATMENT OF CERVICAL DYSTONIA
    Shen, Y.
    Hu, Y.
    Cai, L.
    Li, B.
    Pant, L.
    Jin, L.
    PARKINSONISM & RELATED DISORDERS, 2018, 46 : E56 - E56
  • [4] Prognostic value of positron emission tomography using F-18-fluorodeoxyglucose in patients with cervical cancer undergoing radiotherapy
    Nakamoto, Y
    Eisbruch, A
    Achtyes, ED
    Sugawara, Y
    Reynolds, KR
    Johnston, CM
    Wahl, RL
    GYNECOLOGIC ONCOLOGY, 2002, 84 (02) : 289 - 295
  • [5] Positron emission tomography with F-18-fluorodeoxyglucose in the imaging of liver tumors
    Fujimoto, M
    Mizuta, K
    Kawai, T
    Ishihara, M
    Inai, M
    Toda, Y
    GASTROENTEROLOGY, 2004, 126 (04) : A726 - A726
  • [6] Staging of esophageal cancer with F-18-fluorodeoxyglucose positron emission tomography
    Flanagan, FL
    Dehdashti, F
    Siegel, BA
    Trask, DD
    Sundaresan, SR
    Patterson, GA
    Cooper, DJ
    AMERICAN JOURNAL OF ROENTGENOLOGY, 1997, 168 (02) : 417 - 424
  • [7] F-18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging in a Patient with HIV (-) Kaposi Sarcoma
    Cengiz, Arzu
    Savk, Ekin
    Tataroglu, Canten
    Yurekli, Yakup
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2016, 25 (03) : 140 - 142
  • [8] Aortitis diagnosed by F-18-fluorodeoxyglucose positron emission tomography in a patient with syphilis and HIV coinfection
    Kösters, K
    Bleeker-Rovers, CP
    van Crevel, R
    Oyen, WJG
    van der Ven, AJAM
    INFECTION, 2005, 33 (5-6) : 387 - 389
  • [9] Antituberculosis Treatment for a Patient With Massive Ascites The Role of F-18-Fluorodeoxyglucose Positron Emission Tomography
    Yahata, Tetsuro
    Itsukaichi, Mina
    Mashima, Yasuoki
    Tanaka, Kenichi
    OBSTETRICS AND GYNECOLOGY, 2010, 116 (02): : 523 - 525
  • [10] F-18-fluorodeoxyglucose positron emission tomography and the prognosis of patients with pancreatic adenocarcinoma
    Nakata, B
    Chung, YS
    Nishimura, S
    Nishihara, T
    Sakurai, Y
    Sawada, T
    Okamura, T
    Kawabe, J
    Ochi, H
    Sowa, M
    CANCER, 1997, 79 (04) : 695 - 699
12345